Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Shares Issued (2023 - 2025)

Historic Shares Issued for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $48.3 million.

  • CG Oncology's Shares Issued changed N/A to $48.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $272.1 million, marking a year-over-year decrease of 3309.08%. This contributed to the annual value of $406.4 million for FY2024, which is 1942017.29% up from last year.
  • Latest data reveals that CG Oncology reported Shares Issued of $48.3 million as of Q3 2025.
  • In the past 5 years, CG Oncology's Shares Issued registered a high of $406.4 million during Q1 2024, and its lowest value of $19000.0 during Q2 2025.
  • Moreover, its 3-year median value for Shares Issued was $682000.0 (2025), whereas its average is $75.6 million.
  • In the last 5 years, CG Oncology's Shares Issued skyrocketed by 59756176.47% in 2024 and then crashed by 9983.22% in 2025.
  • Over the past 3 years, CG Oncology's Shares Issued (Quarter) stood at $262000.0 in 2023, then surged by 85052.67% to $223.1 million in 2024, then tumbled by 78.35% to $48.3 million in 2025.
  • Its Shares Issued stands at $48.3 million for Q3 2025, versus $19000.0 for Q2 2025 and $682000.0 for Q1 2025.